JD vs. CRSP
JD (JD.com, Inc.) and CRSP (CRISPR Therapeutics AG) are both stocks. JD operates in Internet Retail (Consumer Cyclical), while CRSP operates in Biotechnology (Healthcare). Over the past 5 years, JD returned -15.08%/yr vs -12.85%/yr for CRSP. At a 0.30 correlation, their price movements are largely independent.
Performance
JD vs. CRSP - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, JD achieves a 5.33% return, which is significantly lower than CRSP's 8.60% return.
JD
- 1D
- -0.75%
- 1M
- -1.65%
- YTD
- 5.33%
- 6M
- 1.65%
- 1Y
- -9.30%
- 3Y*
- -4.09%
- 5Y*
- -15.08%
- 10Y*
- 3.63%
CRSP
- 1D
- 9.35%
- 1M
- 8.72%
- YTD
- 8.60%
- 6M
- -2.11%
- 1Y
- 49.67%
- 3Y*
- -3.33%
- 5Y*
- -12.85%
- 10Y*
- —
JD vs. CRSP - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
JD JD.com, Inc. | 5.33% | -14.78% | 23.45% | -47.76% | -17.87% | -20.28% | 149.50% | 68.32% | -49.47% | 62.81% |
CRSP CRISPR Therapeutics AG | 8.60% | 33.23% | -37.12% | 54.00% | -46.36% | -50.51% | 151.39% | 113.18% | 21.68% | 15.89% |
Correlation
The correlation between JD and CRSP is 0.23, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.23 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.26 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.32 |
Correlation (All Time) Calculated using the full available price history since Oct 20, 2016 | 0.30 |
Fundamentals
JD:
$41.81B
CRSP:
$5.47B
JD:
$9.38
CRSP:
-$6.24
JD:
0.03
CRSP:
1.26K
JD:
0.19
CRSP:
3.01
JD:
$1.32T
CRSP:
$4.10M
JD:
$126.44B
CRSP:
-$171.17M
JD:
$27.03B
CRSP:
-$509.21M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
JD vs. CRSP — Risk / Return Rank
JD
CRSP
JD vs. CRSP - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for JD.com, Inc. (JD) and CRISPR Therapeutics AG (CRSP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| JD | CRSP | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.09 | ||
| Sortino ratioReturn per unit of downside risk | -1.75 | ||
| Omega ratioGain probability vs. loss probability | 0.98 | 1.18 | -0.20 |
| Calmar ratioReturn relative to maximum drawdown | -0.31 | 1.18 | -1.49 |
| Martin ratioReturn relative to average drawdown | -0.63 | 1.99 | -2.62 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| JD | CRSP | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.29 | 0.80 | -1.09 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.28 | -0.21 | -0.07 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.08 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.08 | 0.24 | -0.16 |
Drawdowns
JD vs. CRSP - Drawdown Comparison
The maximum JD drawdown since its inception was -79.12%, smaller than the maximum CRSP drawdown of -85.11%. Use the drawdown chart below to compare losses from any high point for JD and CRSP.
Loading charts...
Drawdown Indicators
| JD | CRSP | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -79.12% | -85.11% | +5.99% |
Max Drawdown (1Y)Largest decline over 1 year | -29.78% | -42.25% | +12.47% |
Max Drawdown (3Y)Largest decline over 3 years | -48.10% | -64.91% | +16.81% |
Max Drawdown (5Y)Largest decline over 5 years | -75.63% | -80.68% | +5.05% |
Max Drawdown (10Y)Largest decline over 10 years | -79.12% | — | — |
Current DrawdownCurrent decline from peak | -68.83% | -72.89% | +4.06% |
Average DrawdownAverage peak-to-trough decline | -37.57% | -49.18% | +11.61% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 14.82% | 24.97% | -10.15% |
Volatility
JD vs. CRSP - Volatility Comparison
The current volatility for JD.com, Inc. (JD) is 12.35%, while CRISPR Therapeutics AG (CRSP) has a volatility of 17.25%. This indicates that JD experiences smaller price fluctuations and is considered to be less risky than CRSP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| JD | CRSP | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.35% | 17.25% | -4.90% |
Volatility (6M)Calculated over the trailing 6-month period | 22.58% | 43.41% | -20.83% |
Volatility (1Y)Calculated over the trailing 1-year period | 32.37% | 62.30% | -29.93% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 53.77% | 60.58% | -6.81% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 47.82% | 64.33% | -16.51% |
Dividends
JD vs. CRSP - Dividend Comparison
JD's dividend yield for the trailing twelve months is around 3.43%, while CRSP has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
CRSP CRISPR Therapeutics AG | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
JD JD.com, Inc. | 3.43% | 3.48% | 2.19% | 2.15% | 2.24% |
Financials
JD vs. CRSP - Financials Comparison
This section allows you to compare key financial metrics between JD.com, Inc. and CRISPR Therapeutics AG. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
JD and CRSP have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CRSP has higher volatility (17.25%) compared to JD (12.35%). In terms of maximum drawdown, JD dropped -79.12% vs CRSP's -85.11%.
CRSP currently has the higher Sharpe Ratio (0.80 vs -0.29), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for JD and CRSP
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer